Taysha Gene Therapies, Inc.
Nasdaq TSHA · Dallas, TX
Works in Genetic & rare · Metabolic & endocrine · Neurology · Psychiatry
Taysha Gene Therapies, Inc. is a clinical trial sponsor based in Dallas, TX, listed as Nasdaq TSHA. It has 3 active clinical trials with 27 planned participants, in Genetic & rare, Metabolic & endocrine, Neurology and Psychiatry. Since 2021 it has completed 0 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq TSHA
Fundraising
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Taysha Gene Therapies, Inc
Taysha Gene Therapies, Inc is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 27 planned participants, in Genetic & rare, Metabolic & endocrine, Neurology, Psychiatry. Since 2021 it has completed 0 trials and stopped 1 early.
Taysha Gene Therapies, Inc is based in Dallas, TX and is listed as Nasdaq TSHA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Taysha Gene Therapies, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-19.
Approve Suite is not affiliated with Taysha Gene Therapies, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.